BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Afonso MB, Rodrigues PM, Mateus-Pinheiro M, Simão AL, Gaspar MM, Majdi A, Arretxe E, Alonso C, Santos-Laso A, Jimenez-Agüero R, Eizaguirre E, Bujanda L, Pareja MJ, Banales JM, Ratziu V, Gautheron J, Castro RE, Rodrigues CMP. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease. Gut 2021;70:2359-72. [PMID: 33361348 DOI: 10.1136/gutjnl-2020-321767] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang M, Chen W, He L, Liu D, Zhao L, Wang X. A Glimpse of necroptosis and diseases. Biomedicine & Pharmacotherapy 2022;156:113925. [DOI: 10.1016/j.biopha.2022.113925] [Reference Citation Analysis]
2 Tuero C, Becerril S, Ezquerro S, Neira G, Frühbeck G, Rodríguez A. Molecular and cellular mechanisms underlying the hepatoprotective role of ghrelin against NAFLD progression. J Physiol Biochem 2022. [DOI: 10.1007/s13105-022-00933-1] [Reference Citation Analysis]
3 Liu J, Ji S, Liu Z, Guo M, Chen L. Deletion of Cyclic GMP-AMP Synthase Accelerates Concanavalin A-Induced Acute Hepatic Injury by Facilitating Leukocyte Chemotaxis.. [DOI: 10.21203/rs.3.rs-2228591/v1] [Reference Citation Analysis]
4 Hou B, Liu M, Chen Y, Ni W, Suo X, Xu Y, He Q, Meng X, Hao Z. Cpd-42 protects against calcium oxalate nephrocalcinosis-induced renal injury and inflammation by targeting RIPK3-mediated necroptosis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1041117] [Reference Citation Analysis]
5 Phung HH, Lee CH. Mouse models of nonalcoholic steatohepatitis and their application to new drug development. Arch Pharm Res 2022. [DOI: 10.1007/s12272-022-01410-5] [Reference Citation Analysis]
6 Magusto J, Beaupère C, Afonso MB, Auclair M, Delaunay J, Soret P, Courtois G, Aït-slimane T, Housset C, Jéru I, Fève B, Ratziu V, Rodrigues CM, Gautheron J. The necroptosis-inducing pseudokinase mixed lineage kinase domain-like regulates the adipogenic differentiation of pre-adipocytes. iScience 2022;25:105166. [DOI: 10.1016/j.isci.2022.105166] [Reference Citation Analysis]
7 Hildebrandt X, Ibrahim M, Peltzer N. Cell death and inflammation during obesity: “Know my methods, WAT(son)”. Cell Death Differ 2022. [DOI: 10.1038/s41418-022-01062-4] [Reference Citation Analysis]
8 Mohammed S, Thadathil N, Tran AL, Van Der Veldt M, Georgescu C, Haritha NH, Ohene-marfo P, Oh S, Nicklas EH, Wang D, Luo W, Janknecht R, Miller BF, Wren JD, Freeman W, Deepa SS. Blocking necroptosis reduces inflammation and tumor incidence in a mouse model of diet-induced hepatocellular carcinoma.. [DOI: 10.1101/2022.08.03.502666] [Reference Citation Analysis]
9 Chehade L, Deguise M, De Repentigny Y, Yaworski R, Beauvais A, Gagnon S, Hensel N, Kothary R. Suppression of the necroptotic cell death pathways improves survival in Smn2B/− mice. Front Cell Neurosci 2022;16:972029. [DOI: 10.3389/fncel.2022.972029] [Reference Citation Analysis]
10 Dai J, Fu Y. Identification of necroptosis‐related gene signature and characterization of tumour microenvironment infiltration in non‐small‐cell lung cancer. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17494] [Reference Citation Analysis]
11 El-Demiry SM, El-Yamany M, El-Gendy SM, Salem HA, Saber MM. Necroptosis modulation by cisplatin and sunitinib in hepatocellular carcinoma cell line. Life Sci 2022;301:120594. [PMID: 35500680 DOI: 10.1016/j.lfs.2022.120594] [Reference Citation Analysis]
12 Oka K, Fujioka S, Kawamura Y, Komohara Y, Chujo T, Sekiguchi K, Yamamura Y, Oiwa Y, Omamiuda-Ishikawa N, Komaki S, Sutoh Y, Sakurai S, Tomizawa K, Bono H, Shimizu A, Araki K, Yamamoto T, Yamada Y, Oshiumi H, Miura K. Resistance to chemical carcinogenesis induction via a dampened inflammatory response in naked mole-rats. Commun Biol 2022;5:287. [PMID: 35354912 DOI: 10.1038/s42003-022-03241-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Nicolè L, Sanavia T, Cappellesso R, Maffeis V, Akiba J, Kawahara A, Naito Y, Radu CM, Simioni P, Serafin D, Cortese G, Guido M, Zanus G, Yano H, Fassina A. Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3+ and CD8+ T cell density and predict prognosis in hepatocellular carcinoma. J Immunother Cancer 2022;10:e004031. [PMID: 35264437 DOI: 10.1136/jitc-2021-004031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Puengel T, Liu H, Guillot A, Heymann F, Tacke F, Peiseler M. Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2022;23:2668. [PMID: 35269812 DOI: 10.3390/ijms23052668] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
15 Zhou Y, Wu R, Wang X, Bao X, Lu C. Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis. Cell Prolif 2022;:e13193. [PMID: 35083817 DOI: 10.1111/cpr.13193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
16 Feng Z, Xiang J, Liu H, Li J, Xu X, Sun G, Zheng R, Zhang S, Liu J, Yang S, Xu Q, Wen X, Yuan H, Sun H, Dai L. Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis. J Med Chem . [DOI: 10.1021/acs.jmedchem.1c02002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Wang R, Yao L, Lin X, Hu X, Wang L. Exploring the potential mechanism of Rhodomyrtus tomentosa (Ait.) Hassk fruit phenolic rich extract on ameliorating nonalcoholic fatty liver disease by integration of transcriptomics and metabolomics profiling. Food Res Int 2022;151:110824. [PMID: 34980375 DOI: 10.1016/j.foodres.2021.110824] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
18 Tsurusaki S, Kanegae K, Tanaka M. In Vivo Analysis of Necrosis and Ferroptosis in Nonalcoholic Steatohepatitis (NASH). Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2128-8_21] [Reference Citation Analysis]
19 Gallego-Durán R, Montero-Vallejo R, Maya-Miles D, Lucena A, Martin F, Ampuero J, Romero-Gómez M. Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases. Front Immunol 2021;12:667354. [PMID: 34899679 DOI: 10.3389/fimmu.2021.667354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lou J, Wang X, Zhang H, Yu G, Ding J, Zhu X, Li Y, Wu Y, Xu H, Xu H, Gao W, Xiao J, Zhou K. Inhibition of PLA2G4E/cPLA2 promotes survival of random skin flaps by alleviating Lysosomal membrane permeabilization-Induced necroptosis. Autophagy 2021;:1-23. [PMID: 34872436 DOI: 10.1080/15548627.2021.2002109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]